| Teva Pharma AG - Sunitinib-Teva 25 mg, Hartkapseln | | 67781 | | 02 | | Sunitinib-Teva 25 mg | | Hartkapseln | | L01EX01 | | | | 15.02.2021 | | |
| | Composition | | sunitinibum 25 mg, mannitolum, povidonum K 25, carmellosum natricum conexum corresp. natrium max. 0.15 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Sunitinib | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Sunitinib | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | | | | Mannitol | | | | | 25 | | | | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 28 | 1601.50 | 1758.15 | A | LS | Non |
|
|
